Back to Journals » Journal of Hepatocellular Carcinoma » Volume 10
Review
Evidence to Date: Clinical Utility of Tremelimumab in the Treatment of Unresectable Hepatocellular Carcinoma
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
1,565 | Dovepress* | 1,398+ | 40 | 1,438 | |
PubMed Central* | 167 | 91 | 258 | ||
Totals | 1,565 | 131 | 1,696 | ||
*Since 27 October 2023 |
View citations on PubMed Central and Google Scholar